NIH-funded research R01 grant

More accurate lupus kidney diagnosis using new imaging biomarkers

Official title: Improving the Accuracy of Lupus Nephritis Diagnosis using Biomarkers Derived from Ultraviolet and Mid-infrared Spectroscopic Imaging

Funded at University of Houston · NIH-11237166 · Data updated 2026-11-12

This project uses two advanced imaging methods plus AI to help doctors read kidney biopsies more accurately for people with lupus nephritis.

More Lupus research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startJanuary 1, 2024
Project endNovember 30, 2028
Funding year2026
Award (this year)$638,616
NIH project number5R01DK135870-03
Project IDNIH-11237166 on NIH RePORTER

Who could benefit from this research

Could help

People with lupus nephritis who are having a kidney biopsy or who can provide existing kidney biopsy tissue for research would be the best candidates.

Less likely to help

People without lupus kidney involvement or those who cannot provide biopsy tissue would not directly benefit from this diagnostic-focused work.

What this research studies

Current kidney biopsy readings for lupus nephritis can vary between pathologists and miss important molecular details. This project combines two optical imaging methods (ultraviolet surface excitation and mid‑infrared spectroscopic imaging) to capture protein and biochemical signals from biopsy tissue. The team will align images from both methods, extract new structural and molecular features, and use a deep‑learning model to combine those features. They will test the approach in mouse models and then validate the diagnostic markers using archived human kidney biopsy samples.

Why it matters

Potential benefit: If successful, this could lead to more accurate and consistent lupus nephritis diagnoses that help guide better treatment decisions.

How similar studies have gone: Related imaging and machine‑learning methods have shown promise in laboratory and preclinical work, but combining MUSE and mid‑infrared imaging for human lupus nephritis diagnosis is a novel approach that still needs clinical validation.

Where this research is happening

  • University of Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Reddy, Rohith — University of Houston
  • Study coordinator: Reddy, Rohith

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.